ContraFect Corporation
LYSIN CF-301 RESENSITIZES METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUA (MRSA) TO PENICILLIN DERIVATIVES AND FIRST GENERATION CEPHALOSPORINS
Last updated:
Abstract:
Disclosed are methods of resensitizing a Gram-positive bacterium in a subject to at least one .beta.-lactam antibiotic, comprising co-administering the Gram-positive bacterium with the at least one .beta.-lactam antibiotic and a lysin polypeptide, thereby resensitizing the Gram-positive bacterium in the subject to the at least one .beta.-lactam antibiotic.
Status:
Application
Type:
Utility
Filling date:
21 Jun 2019
Issue date:
26 Aug 2021